Newsroom | 11766 results
Sorted by: Latest
-
Lubrizol Announces an Important Milestone for Its Novel Patented Excipient, Apisolex™ Polymer
CLEVELAND--(BUSINESS WIRE)--Lubrizol announces that an Apisolex™ polymer excipient-enabled drug formulation is in Phase 1 clinical trials. Introduced to the market in 2022, Apisolex polymer excipient is a polyamino acid-based polymer that enhances the solubility of BCS Class II and IV active pharmaceutical ingredients (API). Apisolex polymer excipient is manufactured following Good Manufacturing Practices (GMP) guidelines and can be used in dosage forms for various routes of administration, inc...
-
GE Appliances Opens Onsite Advanced Primary Care Clinic for Monogram Refrigeration LLC Employees and Families in Tennessee
SELMER, Tenn.--(BUSINESS WIRE)--America’s #1 Appliance Company1, GE Appliances, a Haier company, today announced the opening of a new onsite advanced primary care clinic at its Monogram Refrigeration LLC plant in Selmer, Tennessee. This state-of-the-art clinic will serve employees and their covered family members (age two and older), marking the first workplace-based health clinic of its kind in McNairy County. The new advanced primary care clinic is in addition to the traditional health covera...
-
Agiliti Introduces New Line of Stretcher Support Surfaces
MINNEAPOLIS--(BUSINESS WIRE)--Agiliti, a leading manufacturer and provider of medical device solutions to the U.S. healthcare industry, today announced the launch of its new NP Line™ of stretcher support surfaces clinically engineered for safer patient care. “Stretcher pads are among the most used pieces of medical equipment in Emergency and Perioperative Departments and subject to rapid wear and tear,” said Tim McCarty, General Manager of Beds and Therapeutic Support Surfaces at Agiliti. “We d...
-
Harrow Acquires U.S. Commercial Rights to BYQLOVI™ (Clobetasol Propionate Ophthalmic Suspension) 0.05% from Formosa Pharmaceuticals
NASHVILLE, Tenn. & TAIPEI, Taiwan--(BUSINESS WIRE)--Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, and Taiwan-based Formosa Pharmaceuticals (“Formosa”, 6838.TW), today announced a licensing agreement, whereby Harrow has acquired the exclusive U.S. commercial rights for BYQLOVI™ (clobetasol propionate ophthalmic suspension) 0.05%. BYQLOVI was recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of post-operative inflammation and pain...
-
The Blood Connection Celebrates Clemson University’s Alpha Phi Omega Being Named School Partner of the Year
CLEMSON, S.C.--(BUSINESS WIRE)--The Blood Connection (TBC) and Clemson University’s Alpha Phi Omega Gamma Lambda (APO) chapter were named by the Association for Donor Recruitment Professionals (ADRP) as the School Partner of the Year. This award recognizes outstanding dedication to saving lives within Clemson’s student body and local community. This award celebrates the exceptional commitment demonstrated by Clemson APO in fostering a culture of altruistic donors throughout the years. “It’s an...
-
MeMed BV Surpasses 100,000 Patient Tests, Underscoring Adoption of Rapid Host-Response Diagnostics
ANDOVER, Mass. & HAIFA, Israel--(BUSINESS WIRE)--100,000 patients have now been tested with MeMed BV, a host-response diagnostic that accurately distinguishes between bacterial and viral infections....
-
Publication in Vaccines Highlights Important Benefits of PharmaJet® Tropis® Intradermal Vaccination over Intramuscular Standard of Care
GOLDEN, Colo.--(BUSINESS WIRE)--Publication in Vaccines highlights that when compared to the SoC in an RI study, Tropis demonstrated increased coverage, cost savings and preference....
-
Owens & Minor and Rotech Healthcare Mutually Agree to Terminate Previously Announced Acquisition
RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor, Inc. (NYSE: OMI) today announced it has mutually agreed with Rotech Healthcare Holdings Inc. to terminate the previously announced acquisition. Under the terms of the merger agreement, Owens & Minor has paid $80 million to Rotech Healthcare. Owens & Minor will also redeem the $1 billion of notes issued in April 2025, which include a special mandatory redemption provision in accordance with their terms, and terminate the incremental term...
-
TransLogic Promotes Jeff Huntington to VP of Engineering for North America
BROOMFIELD, Colo.--(BUSINESS WIRE)--TransLogic, a Swisslog Healthcare company and global leader in transport automation solutions, announces the promotion of Jeff Huntington to Vice President of Engineering for North America. In his new role, Huntington will oversee Software Development, Mechatronics, and the System Design & Sustaining Engineering Support teams for TransLogic products. "At TransLogic, we create products that transform how healthcare facilities operate," said Jeff Huntington...
-
Bausch + Lomb Launches Blink® Nourish Lubricating Eye Drops and Blink Boost Lubricating Eye Drops in the United States
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of Blink Nourish Lubricating eye drops and Blink Boost Lubricating eye drops. Both products are preservative-free, contact-lens friendly and uniquely formulated to provide hydration and comfort for dry eyes in a multi-dose bottle. "Blink Nourish and Blink Boost deliver the same science-backed, lo...